These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1294668)
1. [Significance of normal oral flora, particularly group oral streptococci as defense mechanism against infection in healthy individuals (normal defense mechanism by oral Streptococcus group)]. Fujimori I; Yamada T; Kikushima K; Goto R; Ogino J; Hisamatsu K; Murakami Y Kansenshogaku Zasshi; 1992 Dec; 66(12):1634-8. PubMed ID: 1294668 [TBL] [Abstract][Full Text] [Related]
2. [Isolation of alpha-streptococci with inhibitory activity against pathogens, in the oral cavity and the effect of tobacco and gargling on oral flora]. Fujimori I; Goto R; Kikushima K; Ogino J; Hisamatsu K; Murakami Y; Yamada T Kansenshogaku Zasshi; 1995 Feb; 69(2):133-8. PubMed ID: 7745286 [TBL] [Abstract][Full Text] [Related]
3. [Incidence of alpha-streptococcus having inhibitory activity against beta-streptococcus in patients with tonsillitis]. Fujimori I; Yamada T Nihon Jibiinkoka Gakkai Kaiho; 1992 Mar; 95(3):400-8. PubMed ID: 1569518 [TBL] [Abstract][Full Text] [Related]
4. Analysis of defense mechanisms against bacterial infection by oral streptococcus in normal flora. Fujimori I; Kikushima K; Hisamatsu KI; Nozawa I; Goto R; Murakami Y Zentralbl Bakteriol; 1996 Sep; 285(1):74-81. PubMed ID: 8946698 [TBL] [Abstract][Full Text] [Related]
6. Investigation of oral alpha-streptococcus showing inhibitory activity against pathogens in children with tonsillitis. Fujimori I; Goto R; Kikushima K; Hisamatsu K; Murakami Y; Yamada T Int J Pediatr Otorhinolaryngol; 1995 Nov; 33(3):249-55. PubMed ID: 8557481 [TBL] [Abstract][Full Text] [Related]
7. Interaction between oral alpha-streptococci and group A streptococci in patients with tonsillitis. Fujimori I; Kikushima K; Hisamatsu K; Nozawa I; Goto R; Murakami Y Ann Otol Rhinol Laryngol; 1997 Jul; 106(7 Pt 1):571-4. PubMed ID: 9228858 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory substances produced by Streptococcus salivarius and colonization of the upper respiratory tract with group A streptococci. Huskins WC; Kaplan EL Epidemiol Infect; 1989 Jun; 102(3):401-12. PubMed ID: 2500355 [TBL] [Abstract][Full Text] [Related]
9. Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococci. Sanders CC; Sanders WE J Infect Dis; 1982 Nov; 146(5):683-90. PubMed ID: 6752297 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the nasopharyngeal bacterial flora in children with otitis media with effusion. Fujimori I; Kikushima K; Goto R; Hisamatsu K; Murakami Y; Yamada T ORL J Otorhinolaryngol Relat Spec; 1996; 58(3):147-50. PubMed ID: 8797218 [TBL] [Abstract][Full Text] [Related]
11. Streptococci and aerococci associated with systemic infection in man. Parker MT; Ball LC J Med Microbiol; 1976 Aug; 9(3):275-302. PubMed ID: 785000 [TBL] [Abstract][Full Text] [Related]
12. [Quantitative analyses of the normal throat flora of children with upper respiratory tract infections]. Yoshinaga M; Masuda K; Takase M; Shigemori M; Shimago A; Kuwahata M; Nagamatsu S; Miyata K; Miyanohara H; Nagai T Kansenshogaku Zasshi; 1992 Aug; 66(8):1105-12. PubMed ID: 1402117 [TBL] [Abstract][Full Text] [Related]
13. Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A streptococci. Sanders CC; Nelson GE; Sanders WE Infect Immun; 1977 May; 16(2):599-603. PubMed ID: 324915 [TBL] [Abstract][Full Text] [Related]
14. Penicillin tolerance among oral streptococci. Holbrook WP; Olafsdóttir D; Magnússon HB; Benediktsdóttir E J Med Microbiol; 1988 Sep; 27(1):17-22. PubMed ID: 3050106 [TBL] [Abstract][Full Text] [Related]
15. [Antibiotic therapy against acute tonsillopharyngitis in children due to group A beta-hemolytic streptococci: comparison of clinical efficacy, the bactericidal effects, and effects on oral flora between cefditoren pivoxil for 5 days and amoxicillin for 10 days]. Tsumura N; Nagai K; Hidaka H; Otsu Y; Tanaka Y; Ikezawa S; Honma S; Shindo S; Ubukata K Jpn J Antibiot; 2011 Jun; 64(3):179-90. PubMed ID: 21861309 [TBL] [Abstract][Full Text] [Related]
16. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Tagg JR Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154 [TBL] [Abstract][Full Text] [Related]
17. Establishment of streptococci in the upper respiratory tract: longitudinal changes in the mouth and nasopharynx up to 2 years of age. Könönen E; Jousimies-Somer H; Bryk A; Kilpi T; Kilian M J Med Microbiol; 2002 Sep; 51(9):723-730. PubMed ID: 12358062 [TBL] [Abstract][Full Text] [Related]
18. Acute otitis media caused by Streptococcus pyogenes in children. Segal N; Givon-Lavi N; Leibovitz E; Yagupsky P; Leiberman A; Dagan R Clin Infect Dis; 2005 Jul; 41(1):35-41. PubMed ID: 15937760 [TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Di Pierro F; Adami T; Rapacioli G; Giardini N; Streitberger C Expert Opin Biol Ther; 2013 Mar; 13(3):339-43. PubMed ID: 23286823 [TBL] [Abstract][Full Text] [Related]
20. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Roos K; Holm SE; Grahn E; Lind L Scand J Infect Dis; 1993; 25(1):31-5. PubMed ID: 8460346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]